01 / DESIGN
What was studied?
Biophysical membrane assays and neuroblastoma-cell experiments examined alpha-synuclein binding, aggregation and mitochondrial stress.
02 / FINDINGS
What did the researchers report?
SS-31 altered membrane binding and aggregation patterns and improved selected cell-viability and respiration measurements after exposure to oligomers.
03 / LIMITS
How should it be interpreted?
Artificial membranes and cell lines simplify a complex disease process. The work does not establish prevention or treatment of Parkinson's disease in humans.
Loti Labs Peptide editorial reading note. Based on the linked source record. Methods and corrections.